Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?

Gastroenterology

Volumn 122, Issue 4, 2002, Pages 1140-1156

  Whitehead, William E ^a   Palsson, Olafur ^a   Jones, Kenneth R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY NEUROSIS; CHRONIC FATIGUE SYNDROME; COMORBIDITY; DEPRESSION; FIBROMYALGIA; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; MENTAL DISEASE; NEUROSIS; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; TEMPOROMANDIBULAR JOINT DISORDER;

EID: 0036202892     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.32392     Document Type: Article

References (173)

1. Intergenerational transmission of gastrointestinal illness behavior
2. Psychosocial factors in the irritable bowel syndrome: A multivariate study of patients and non-patients with irritable bowel syndrome
3. Comorbid conditions in patients with irritable bowel syndrome: Data from a national IBS awareness registry
4. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic" symptomatology
5. Costs of care for irritable bowel syndrome patients in a health maintenance organization
6. Irritable bowel-type symptoms in HMO examinees: Prevalence, demographics, and clinical correlates
7. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia
8. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome
9. The sense of coherence index and the irritable bowel syndrome: A cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls
10. Somatization: A spectrum of severity
11. Affective spectrum disorder: Does antidepressant response identify a family of disorders with a common pathophysiology?
12. The pathogenesis of chronic pain and fatigue syndromes, with special reference to fibromyalgia
13. Fibromyalgia syndrome: Blueprint for a reliable diagnosis
14. Nongastrointestinal disorders in the irritable bowel syndrome
15. Intestinal and extraintestinal symptoms in functional gastrointestinal disorders
16. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee
17. The prevalence and characteristics of fibromyalgia in the general population
18. Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications
19. Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome
20. Primary fibromyalgia and the irritable bowel syndrome: Different expressions of a common pathogenetic process
21. A controlled study of primary fibromyalgia syndrome: Clinical features and association with other functional syndromes
22. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
23. Fibromyalgia in men: Comparison of clinical features with women
24. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients
25. The prevalence and characteristics of fibromyalgia in the general population
26. Coexistence of irritable bowel syndrome and fibromyalgia
27. Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points
28. Fibromyalgia syndrome: An emerging but controversial condition
29. Bowel dysfunction in fibromyalgia syndrome
30. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder
31. Comorbidity of fibromyalgia with medical and psychiatric disorders
32. Chronic fatigue syndrome: A working case definition
33. Chronic fatigue syndrome: Point and counterpoint
34. A community-based study on chronic fatigue syndrome
35. The relationship between temporomandibular disorders and stress-associated syndromes
36. Prevalence of irritable bowel syndrome in chronic fatigue
37. Chronic fatigue syndrome in psychiatric patients: Lifetime and premorbid personal history of physical health
38. Comorbid clinical conditions in chronic fatigue: A co-twin control study
39. The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome
40. Comorbid disorders and symptoms in irritable bowel syndrome (IBS) compared to other gastroenterology patients
41. The prevalence of chronic pelvic pain and irritable bowel syndrome in two university clinics
42. Patterns of diagnosis referral in women consulting for chronic pelvic pain in U.K. primary care
43. Irritable bowel syndrome in women having diagnostic laparoscopy or hysterectomy: Relation to gynecologic features and outcome
44. Gynaecological consultation in patients with the irritable bowel syndrome
45. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications
46. An epidemiological comparison of pain complaints
47. Temporomandibular disorders: A clinical update
48. Interstitial cystitis: Unexplained associations with other chronic disease and pain syndromes
49. U.S. householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impacts
50. Irritable bowel syndrome in the gynecological clinic: Survey of 798 new referrals
51. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population
52. A review of the evidence for overlap among unexplained clinical conditions
53. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome
54. Irritable bowel syndrome: Physiological and psychological differences between diarrhea-predominant and constipation-predominant patients
55. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
56. The autonomic nervous system in functional bowel disorders
57. Irritable bowel syndrome: A technical review for practice guideline development
58. Postprandial plasma 5-hydroxytryptamine in diarrhoea-predominant irritable bowel syndrome: A pilot study
59. The role of psychological and biological factors in postinfective gut dysfunction
60. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients
61. Stress, inflammation and the irritable bowel syndrome
62. Alterations in colonic function in man under stress. I. Experimental production of changes simulating the "irritable colon"
63. Effects of stressful life events on bowel symptoms: Subjects with irritable bowel syndrome compared with subjects without bowel dysfunction
64. Irritable bowel syndrome and sexual/physical abuse history
65. Prevalence of sexual abuse among patients with functional disorders of the lower gastrointestinal tract
66. Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease
67. Tolerance for rectosigmoid distention in irritable bowel syndrome
68. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects
69. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia
70. Visceral algesia in irritable bowel syndrome, fibromyalgia, and sphincter of Oddi dysfunction, type III
71. Autonomic regulation of cardiac function during sleep in patients with irritable bowel syndrome
72. Spectral analysis of heart rate variability in patients with irritable bowel syndrome
73. Characterization of autonomic dysfunction in patients with irritable bowel syndrome by means of heart rate variability studies
74. Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities
75. Altered skin temperature and electromyographic activity in the irritable bowel syndrome
76. Autonomic nervous system reactivity in irritable bowel syndrome
77. Evidence for autonomic nervous system imbalance in women with irritable bowel syndrome
78. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: A hospital-based Oriental study
79. Abnormal vagal function in irritable bowel syndrome
80. Autonomic nervous system function in women with irritable bowel syndrome
81. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls
82. Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome
83. Autonomic function in patients with chronic fatigue syndrome
84. Autonomic testing in patients with chronic fatigue syndrome
85. Does the chronic fatigue syndrome involve the autonomic nervous system?
86. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome
87. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion
88. The postural orthostatic tachycardia syndrome: A potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents
89. Sympathetic overactivity in subjects complaining of unexplained fatigue
90. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability
91. Abnormal sympathovagal balance in men with fibromyalgia
92. Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis
93. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea
94. Symptom patterns in long-duration chronic fatigue syndrome
95. 5-Hydroxytryptamine-4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine
96. Irritable bowel syndrome: New agents targeting serotonin receptor subtypes
97. Evidence-based data on pain relief with antidepressants
98. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta-analysis
99. What determines severity among patients with painful functional bowel disorders?
100. Extraintestinal symptoms in patients with irritable bowel syndrome (IBS)
101. Non-colonic features of irritable bowel syndrome
102. Sexual and physical abuse in women with functional or organic gastrointestinal disorders
103. Irritable bowel-type symptoms in HMO examinees: Prevalence, demographics, and clinical correlates
104. Sexual and physical abuse history in subjects with temporomandibular disorders: Relationship to clinical variables, pain sensitivity, and psychologic factors
105. Effects of physical and sexual abuse in facial pain: Direct or mediated?
106. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: A controlled study on prevalence and characteristics
107. The prevalence of sexual abuse in women with fibromyalgia
108. Psychiatric diagnoses and sexual victimization in women with chronic pelvic pain
109. Chronic pelvic pain as a somatoform disorder
110. Self-reported abuse history and pain complaints among young adults
111. Domestic violence and sexual abuse in women physicians: Associated medical, psychiatric, and professional difficulties
112. Physical symptoms, somatization, and dissociation in women survivors of childhood sexual assault
113. The functional GI disorders and the Rome II process
114. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception
115. Altered esophageal pain threshold in irritable bowel syndrome
116. Visceral perception in irritable bowel syndrome: Rectal and gastric responses to distension and serotonin type 3 antagonism
117. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome
118. Dysmotility of the small intestine in irritable bowel syndrome
119. Abnormal sensory perception in patients with esophageal chest pain
120. Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia
121. Prevalence of sexual abuse among patients with functional disorders of the lower gastrointestinal tract
122. Gastric emptying and dyspeptic symptoms in the irritable bowel syndrome
123. Role of anger in antral motor activity in irritable bowel syndrome
124. The irritable bowel syndrome: A paroxysmal motor disorder
125. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms
126. Voluntary suppression of defecation delays gastric emptying
127. Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time
128. Functional gut disorders: From motility to sensitivity disorders. A review of current investigational drugs for their management
129. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples
130. Gastrointestinal syndromes defined by factor analysis: Gender and race comparisons
131. Is functional dyspepsia just a subset of the irritable bowel syndrome?
132. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: A four nations study
133. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
134. Comorbidity of posttraumatic stress disorder and irritable bowel syndrome
135. Prevalence of psychiatric disorders in patients with irritable bowel syndrome
136. Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease
137. Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease
138. Anxiety and the gastrointestinal system
139. The irritable colon syndrome and psychiatric illness
140. The relationship between irritable bowel syndrome and psychiatric illness: A family study
141. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the U.S. National Comorbidity Survey 1996
142. An international study of the relation between somatic symptoms and depression
143. Comorbidity of gastrointestinal complaints, depression and anxiety in the Epidemiologic Catchment Area (ECA) study
144. The composite international diagnostic interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures
145. Somatization: The concept and its clinical application
146. Somatization: A debilitating syndrome in primary care
147. Modeling and reinforcement of the sick role during childhood predicts adult illness behavior
148. Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer
149. Effects of psychological distress on perceptions of physical health and use of medical and psychiatric facilities
150. Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: A four nations study
151. Validation of Rome criteria for functional gastrointestinal disorders by factor analysis
152. Latent variable models of functional somatic distress
153. Functional somatic syndromes
154. Functional somatic syndromes: One or many?
155. Visceral nociception: Consequences, modulation and the future
156. Corticotropin-releasing factor and the brain-gut motor response to stress
157. The neurobiology of stress and gastrointestinal disease
158. Psychometric scores and persistence of irritable bowel after infectious diarrhoea
159. Impaired transit and tolerance of intestinal gas in the IBS
160. Presidential address: Gastrointestinal illness and the biopsychosocial model
161. Toward a biobehavioral model of visceral hypersensitivity in IBS
162. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia
163. Irritable bowel syndrome in patients with dyspepsia: A community-based study in southern Europe
164. Functional gastrointestinal disorders and eating disorders: Relevance of the association in clinical management
165. Functional gastrointestinal disorders in unselected patients with non-cardiac chest pain
166. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome
167. The association between non-ulcer dyspepsia and other gastrointestinal disorders
168. Predictors for the course of chronic non-organic upper abdominal pain
169. Dyspepsia and dyspepsia subgroups: A population-based study
170. A database on dyspepsia
171. Functional bowel disorders: Are they independent diagnoses?
172. Non-alimentary aspects of the irritable bowel syndrome